Showing 181 - 200 of 836 results
Australia’s Nuclear Age Celebrates 70 Years
Australia a world leader in silicon industry
Jordan Atomic Energy Commission engineers gain expertise at ANSTO
Sika receives its operating licence
70 years of scientific excellence has brought significant benefits to Australia
ANSTO is a unique national science organisation that began operating under its predecessor The Australian Atomic Energy Commission (AAEC) 70 years ago.
ANSTO Synroc® Treatment Facility
ANSTO Synroc® is constructing an Australian radioactive waste treatment facility for the by-products of Molybdenum-99 (Mo-99) production.
Sutherland Shire locals invited to become ANSTO Citizen Scientists
Highlights - Aerosol Sampling
ANSTO has been tracking and publishing data on fine particle pollution from key sites around Australia, and internationally, for more than 20 years.
Technical Information - Joey
Specifications and Sample environments
Infrastructure - Planetary Materials
At ANSTO we have a large range of facilities that can be used to investigate planetary materials.
Announcement about changes in access arrangements to ANSTO Facilities and Capabilities
Neutron Science Workshop with University of Tokyo
Nuclear science informing risk assessments during offshore decommissioning
Environmental scientists at ANSTO have been undertaking research to gain a better understanding of the potential impact of contaminants on decommissioned offshore oil and gas infrastructure since 2017.
CEO delivers opening remarks at Symposium
Australia and United States strengthen nuclear security collaboration with MoU
Although Australia does not use nuclear energy for power needs, it does have the nuclear capabilities, knowledge, and expertise provided by ANSTO to ensure the national interest in nuclear matters is protected and advanced.
Successfully navigating the challenges of replacing a component in a nuclear reactor
The installation of a cold neutron source (CNS), a component that reduces the energy and speed of the neutrons from a research reactor for use in scientific instruments, was successfully completed in September 2024.
Water usage and discharges
ANSTO provides a summary of water usage and discharge for FY2022 - FY2023
Successful clinical trial for prostate cancer enabled by ANSTO
The new targeted treatment for aggressive prostate cancer, which include lutetium produced at ANSTO, has shown to produce more potent and durable responses in men and with fewer side-effects.
Business case to inform direction of Australian nuclear medicine
Consultant appointed to consider a variety of financial, manufacture and import options.